dengue vaccine
A Shot In The Arm For Dengue Control?
The world's first dengue vaccine is good news, but not a perfect solution.
First Dengue Vaccine In Asia Approved In The Philippines
Dengvaxia®, the world's first dengue vaccine, has been approved for use in the Philippines.
Dengue On The Way To Becoming Endemic In China
Analysis of dengue virus sequences in Southern China suggests that dengue cases may not be isolated, imported incidents as previously thought.
Viral Protein That Triggers Dengue Shock Identified
The discovery that NS1 triggers vascular leakage via TLR4 suggests that drugs against bacterial sepsis could be repurposed to treat dengue.
Dengue Day 2015: Interview With Dr. Joselito Sta. Ana
Sanofi Pasteur is currently the frontrunner in the dengue vaccine race. Joselito Sta. Ana, senior director of Sanofi Pasteur Asia Pacific gives us an update on their plans in Asia.
Dengue Day 2015: Top Dengue Stories On Asian Scientist
Want to catch up on the latest happenings in dengue research over the past year? Look no further!
GHIT Awards Seven New Grants Amounting To US$15.3 Million
Research in the neglected tropical diseases of dengue, malaria and Chagas disease receive a US$15.3 million boost in funding from GHIT.
Sanofi’s Dengue Vaccine Promising But Offers Incomplete Protection
A late-stage clinical trial has shown that Sanofi's dengue vaccine reduces dengue hemorrhagic fever by 89 percent but does not protect against serotype 2.
Sanofi Pasteur Concludes Phase III Trial For Dengue Vaccine
The Phase III trial, which enrolled more than 10,000 children in Asia, showed that vaccination led to a 56 percent reduction in dengue cases.
